A central venous catheter is also known as central line or central venous line. It is a flexible tube, which is inserted into the vein below the right side of the collarbone and guided towards the large vein towards the heart, known as superior vena cava. A central venous catheter is used for administration of various fluids and these fluids can be easily injected into the body of the patients. The fluids include intravenous fluid, blood transfusions, and chemotherapy drugs. The Centers for Disease Control and Prevention (CDC) provided guidelines to prevent intravascular catheter-related infections in 2011, which were further updated in 2017. The guideline covers various important aspects, which are associated with central venous catheters such as appropriate training for healthcare personnel who insert intravascular catheters and the staff who are responsible for surveillance and selection of catheter and catheter application sites.
Global Central Venous Catheter Market - Impact of the Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic is expected to limit growth of the global central venous catheter market over the forecast period. For instance, in June 2020, a study was published in the Current Oncology, a Canadian Cancer Research Journal, which assessed the impact of COVID-19 outbreak on Stage II and Stage III colon cancer patients who were taking adjuvant chemotherapy treatment, in China. According to the study, the patients had to delay or modify their chemotherapy regimens during the COVID-19 outbreak due to the following reasons:
Moreover, the decrease in the number of blood transfusion is expected to hamper growth of the global central venous catheters market. For instance, in November 2021, an article was published in the journal, Transfusion Medicine and Hemotherapy, which stated that during COVID-19 pandemic, more challenges arose for blood transfusion as a result of lockdown, social distancing, and fear of blood virus transmission. Moreover, according to the same source, the elderly, who contributed most to the blood donations, were among the most vulnerable to the virus, resulting in lower donations from them.
The global central venous catheter market is estimated to be valued at US$ 2,117.8 Mn in 2021 and is expected to exhibit a CAGR of 6.2% over the forecast period (2021-2028).
Figure 1: Global Central Venous Catheter Market Share, (%), Analysis, By Product Type, 2021
Market players are engaged in receiving guidelines form the regulatory authorities regarding the classification of the central venous catheters, and this is expected to fuel growth of the global central venous catheter market, over the forecast period
Regulatory authorities are providing guidelines to the market players regarding the classification of the central venous catheter and this is expected to drive growth of the market over the forecast period. For instance, in 2020, Bluegrass Vascular Technologies, a medical technology company, received De Novo classification order from the U.S. Food and Drug Administration (FDA) for its Surfacer Inside-Out Access Catheter System. The system is developed to obtain central venous access for catheter insertion into the central venous system for patients with upper body venous occlusions.
Market players are indulged in inorganic activities such as signing distribution agreements, which is expected to propel growth of the global central venous catheter market, over the forecast period
The increasing inorganic activities by the market players such as signing distribution agreements is expected to drive growth of the global central venous catheter market over the forecast period. For instance, in August 2021, ZOLL Medical and Wallaby Medical Technologies, a medical device company dedicated to stroke treatment, announced a distribution agreement, in which Wallaby will manage the sales and distribution of ZOLL's temperature management products in China. The Thermogard XP Intravascular Temperature Management System (IVTMTM) provides healthcare providers with the precision and speed associated with high-quality targeted temperature management (TTM), resulting in clinically demonstrated improvements in neurological outcomes among cardiac arrest survivors. The system includes a family of heat-exchange catheters that allow clinicians to manage core body temperature based on the patient’s needs.
Global Central Venous Catheter Market – Restraints
The increasing central venous catheter recalls is expected to hamper growth of the global central venous catheter market, over the forecast period. For instance, in January 2020, ICU Medical, Inc., a company manufacturing medical technologies, initiated Class 2 device recall of heparin coated central venous catheter due the inability for the guidewire to pass through the needles included with the catheter kits. Moreover, in January 2019, Arrow International Inc., a part of the Teleflex Inc., initiated the Class 2 Device Recall of Arrow QuadLumen central venous catheterization kit, as the product contained incorrect banner card within the kit.
Furthermore, in February 2016, Cook Medical, a privately held company in the U.S. initiated a voluntary recall of 360 specific lots of Single Lumen Central Venous Catheters and Pressure Monitoring Sets and Trays due to the possibility of catheter tip fracture and/or separation. This recall affected 17,827 devices worldwide. Specific versions and large numbers of the Single Lumen Central Venous Catheter Sets and Trays, Single Lumen Pressure Monitoring Sets, Femoral Artery Pressure Monitoring Catheter Sets and Trays, and Radial Artery Pressure Monitoring Catheter Sets and Trays were recalled. These items are intended for use in venous or arterial pressure monitoring, blood sampling, and drug and fluid administration.
Global Central Venous Catheter Market – Regional Analysis
On the basis of region, global central venous catheter market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Among regions, North America central venous catheter market is expected to hold a dominant position during the forecast period, owing to the availability of reimbursement for the central venous catheter is expected to drive growth of the North America central venous catheter market, over the forecast period. For instance, according to the Centers for Medicare & Medicaid Services (CMS), 2020, the following table shows some of the reimbursement provided for the central venous catheters.
(CPT Stands for Current Procedural Terminology, a trademark of the American Medical Association, ASC – Ambulatory Surgical Center)
|Base Year:||2020||Market Size in 2021:||
US$ 2,117.8 Mn
|Historical Data for:||2018 to 2020||Forecast Period:||2021 to 2028|
|Forecast Period 2021 to 2028 CAGR:||6.2%||2028 Value Projection:||
US$ 3,221.4 Mn
B. Braun Melsungen AG, Becton, Dickinson and Company, ICU Medical, Inc., Poly Medicure Ltd., Teleflex Incorporated, Lepu Medical Technology Co., Ltd., Cook Group, Insung Medical,. VOGT Medical, ZOLL Medical Corporation, EETA Surgical, QMD, and Kimal.
|Restraints & Challenges:||
Furthermore, Europe is also estimated to witness significant growth in the global central venous catheter market, owing to increasing inorganic activities by the market players such as partnerships and agreements. For instance, in March 2018, Bactiguard, a company developing catheters, announced that it entered into a distribution agreement with Ecomed Services NV, a distributor of medical devices in Belgium and the Netherlands, for the commercialization and distribution of Bactiguard products in the Netherlands and expanded its presence in Europe.
|CPT Code||CPT Description||Hospital OPPS Payment (US$)||ASC Payment (US$)|
|36557||The tunneled central venous catheter is inserted without subcutaneous port or pump in patients who are younger than 5 years of age||4,770.37||
|36563||The tunneled central venous catheter is inserted with a subcutaneous pump||4,770.37||
|36566||The tunneled central venous catheterization, requiring 2 catheters via 2 separate venous access sites, with subcutaneous port||4,770.37||
|36556||The non-tunneled central venous catheter is inserted in patients of age 5 years and older||2,861.66||
Figure 2: Global Central Venous Catheter Market (US$ Mn), by Region, 2021
Global Central Venous Catheter Market – Competitive Landscape
Major players operating in the global central venous catheter market include B. Braun Melsungen AG, Becton, Dickinson and Company, ICU Medical, Inc., Poly Medicure Ltd., Teleflex Incorporated, Lepu Medical Technology Co., Ltd., Cook Group, Insung Medical, VOGT Medical, ZOLL Medical Corporation, EETA Surgical, QMD, and Kimal.
Central venous catheterization is applicable to provide medicines in the various therapeutic areas such as cardiology, oncology, and nephrology. Central venous catheterization is used in cardiovascular procedures for drug administration, chemotherapy administration in cancer patients, and hemodialysis of patients with chronic kidney diseases. High prevalence of chronic diseases such as cancer, cardiovascular diseases, and chronic kidney disease (CKD) is propelling demand for central venous catheterization, which is expected to drive the global central venous catheter market growth over the forecast period.
High prevalence of chronic diseases such as cancer, cardiovascular diseases, and chronic kidney disease (CKD) is propelling demand for treatment and care, using central venous catheterization, which in turn is expected to drive the market growth. According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the U.S. According to the same source in 2021, around 659,000 people in the U.S. die from heart disease each year, which is 1 in every 4 deaths.
Moreover, according to the data findings by the World Health Organization (WHO), cancer was a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. According to the same source, the most common cancers were breast cancer (2.26 million cases), lung (2.21 million cases), colon and rectum (1.93 million cases), prostate (1.41 million cases), skin (non-melanoma) (1.20 million cases), and stomach (1.09 million cases).
Development of a device such as central venous catheter, which could reduce time and steps required in central venous catheterization, and make the process much suitable in all kinds of situations is expected to provide a lucrative growth opportunity in the market. For instance, in 2019, an individual designer, ‘Gabriel Mueller’ from Germany developed a central venous catheter named ‘Cevec’ for emergencies such as unsteady surroundings, untrained users, and time pressure.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.